Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2025-12-27 @ 9:15 PM
Study NCT ID:
NCT02311361
Status:
COMPLETED
Last Update Posted:
2021-04-20
First Post:
2014-12-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-05
First Submit QC Date:
None
Study First Post Date:
2014-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-29
Results First Submit QC Date:
None
Results First Post Date:
2020-07-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-26
Last Update Post Date:
2021-04-20
Last Update Post Date Type:
ACTUAL